Microneutralization assay for detection of antibodies against dengue virus serotype 2

Descripción del Articulo

Objective: Adapt the microneutralization test (MNT) to detect neutralizing antibodies against dengue serotype 2 virus (DENV-2) in the Vero-76 cell line.  Materials and methods. Different cellular concentrations (0.6 x 105 cell / mL, 0.9 x 105 cell / mL, 1.2 x 105 cell / mL) and percentages...

Descripción completa

Detalles Bibliográficos
Autores: Sevilla Drozdek, Lucas Augusto, Mayta Huatuco, Egma, Mamani Zapana, Enrique, Reyes Puma, Nora, Vásquez Cajachahua, Karla, Quispe Bravo, Bernardo, Hermosilla Jara, Joe, Quintana Bedoya, Adrián, Sulca Herencia, Juan
Formato: artículo
Fecha de Publicación:2023
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/2538
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/2538
Nivel de acceso:acceso abierto
Materia:Dengue
Serotype
Neutralization
Optimization
Immunoglobulin
id REVCMP_f109c4699dbe694b557b01efea2c6bc8
oai_identifier_str oai:ojs.pkp.sfu.ca:article/2538
network_acronym_str REVCMP
network_name_str Acta Médica Peruana
repository_id_str .
spelling Microneutralization assay for detection of antibodies against dengue virus serotype 2Prueba de microneutralización para detección la de anticuerpos contra el virus dengue serotipo 2Sevilla Drozdek, Lucas AugustoMayta Huatuco, EgmaMamani Zapana, EnriqueReyes Puma, NoraVásquez Cajachahua, KarlaQuispe Bravo, BernardoHermosilla Jara, JoeQuintana Bedoya, AdriánSulca Herencia, JuanDengueSerotypeNeutralizationOptimizationImmunoglobulinObjective: Adapt the microneutralization test (MNT) to detect neutralizing antibodies against dengue serotype 2 virus (DENV-2) in the Vero-76 cell line.  Materials and methods. Different cellular concentrations (0.6 x 105 cell / mL, 0.9 x 105 cell / mL, 1.2 x 105 cell / mL) and percentages of fetal bovine serum (FBS) at 2%, 3% and 4%, passages number of virus stock and incubation days were evaluated. The viral seed was confirmed by RT-qPCR. DENV-2 was propagated by carrying out 5 successive passages in the Vero-76 cell line, then the virus was titrated in microplates and 2 methods were evaluated: complete monolayer and cell suspension, and the optimal coloring day was determined.  Obtained the results, it was evaluated by the MNT for DENV-2: 5 sera negative to DENV-2 and YFV, 5 sera negative to DENV-2 and seropositive to YFV and 5 seropositive sera to DENV-2 confirmed by plaque reduction neutralization test.  The samples were evaluated in triplicate and virus control and cell control were used. Results: The optimal method for MNT uses cells in suspension (0.9 x 105 cell / mL), 2% SBF and viral seed passage 5. The minimum dilution capable of differentiating a DENV-2 seropositive serum from a DENV-2 seronegative sera was 1:40, and the incubation time of the MNT for DENV-2 was 10 days. Conclusion: MNT allows the detection of IgG antibodies against DENV-2, provides reliable results and a greater number of samples can be analyzed with material savings.Objetivo: Estandarizar la prueba de microneutralización (MNT) para detección de anticuerpos neutralizantes contra el virus dengue serotipo 2 (DENV-2) en la línea celular Vero-76.  Materiales y métodos: Se evaluaron diferentes concentraciones celulares (0,6 x105 cel/mL, 0,9 x105 cel/mL, 1,2 x105 cel/mL), porcentajes de 2%, 3% y 4% de suero bovino fetal (SBF), número de pasajes del stock de virus y los días de incubación. La semilla viral se confirmó por RT-qPCR. El DENV-2 se propagó realizando 5 pasajes en células Vero-76, seguidamente se tituló el virus en placas de 96 pozos y se evaluaron 2 métodos de infección celular: monocapa y células en suspensión, además se determinó el día óptimo de coloración de las células. Obtenidos los resultados, se procesaron mediante MNT para DENV-2 las siguientes muestras: 5 sueros negativos a DENV-2 y YFV, 5 sueros negativos a DENV-2 y positivos a YFV y 5 sueros positivos a DENV-2 seleccionados mediante la prueba de neutralización por reducción de placas (PRNT) Resultados: El método óptimo para MNT utilizó células en suspensión (0,9 x 105 cel/mL), 2% de SBF y semilla viral pasaje 5. La mínima dilución capaz de diferenciar una muestra positiva a DENV-2 fue 1:40 y el tiempo de incubación para la MNT para DENV-2 fue de 10 días. Conclusión: La MNT permite detectar anticuerpos neutralizantes IgG contra DENV-2, brinda resultados fiables y se puede analizar un mayor número de muestras con ahorro de materiales.Colegio Médico del Perú2023-08-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/253810.35663/amp.2023.402.2538ACTA MEDICA PERUANA; Vol 40 No 2 (2023): April - JuneACTA MEDICA PERUANA; Vol. 40 Núm. 2 (2023): Abril - Junio1728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/2538/1561Copyright (c) 2023 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/25382024-03-21T00:09:26Z
dc.title.none.fl_str_mv Microneutralization assay for detection of antibodies against dengue virus serotype 2
Prueba de microneutralización para detección la de anticuerpos contra el virus dengue serotipo 2
title Microneutralization assay for detection of antibodies against dengue virus serotype 2
spellingShingle Microneutralization assay for detection of antibodies against dengue virus serotype 2
Sevilla Drozdek, Lucas Augusto
Dengue
Serotype
Neutralization
Optimization
Immunoglobulin
title_short Microneutralization assay for detection of antibodies against dengue virus serotype 2
title_full Microneutralization assay for detection of antibodies against dengue virus serotype 2
title_fullStr Microneutralization assay for detection of antibodies against dengue virus serotype 2
title_full_unstemmed Microneutralization assay for detection of antibodies against dengue virus serotype 2
title_sort Microneutralization assay for detection of antibodies against dengue virus serotype 2
dc.creator.none.fl_str_mv Sevilla Drozdek, Lucas Augusto
Mayta Huatuco, Egma
Mamani Zapana, Enrique
Reyes Puma, Nora
Vásquez Cajachahua, Karla
Quispe Bravo, Bernardo
Hermosilla Jara, Joe
Quintana Bedoya, Adrián
Sulca Herencia, Juan
author Sevilla Drozdek, Lucas Augusto
author_facet Sevilla Drozdek, Lucas Augusto
Mayta Huatuco, Egma
Mamani Zapana, Enrique
Reyes Puma, Nora
Vásquez Cajachahua, Karla
Quispe Bravo, Bernardo
Hermosilla Jara, Joe
Quintana Bedoya, Adrián
Sulca Herencia, Juan
author_role author
author2 Mayta Huatuco, Egma
Mamani Zapana, Enrique
Reyes Puma, Nora
Vásquez Cajachahua, Karla
Quispe Bravo, Bernardo
Hermosilla Jara, Joe
Quintana Bedoya, Adrián
Sulca Herencia, Juan
author2_role author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Dengue
Serotype
Neutralization
Optimization
Immunoglobulin
topic Dengue
Serotype
Neutralization
Optimization
Immunoglobulin
description Objective: Adapt the microneutralization test (MNT) to detect neutralizing antibodies against dengue serotype 2 virus (DENV-2) in the Vero-76 cell line.  Materials and methods. Different cellular concentrations (0.6 x 105 cell / mL, 0.9 x 105 cell / mL, 1.2 x 105 cell / mL) and percentages of fetal bovine serum (FBS) at 2%, 3% and 4%, passages number of virus stock and incubation days were evaluated. The viral seed was confirmed by RT-qPCR. DENV-2 was propagated by carrying out 5 successive passages in the Vero-76 cell line, then the virus was titrated in microplates and 2 methods were evaluated: complete monolayer and cell suspension, and the optimal coloring day was determined.  Obtained the results, it was evaluated by the MNT for DENV-2: 5 sera negative to DENV-2 and YFV, 5 sera negative to DENV-2 and seropositive to YFV and 5 seropositive sera to DENV-2 confirmed by plaque reduction neutralization test.  The samples were evaluated in triplicate and virus control and cell control were used. Results: The optimal method for MNT uses cells in suspension (0.9 x 105 cell / mL), 2% SBF and viral seed passage 5. The minimum dilution capable of differentiating a DENV-2 seropositive serum from a DENV-2 seronegative sera was 1:40, and the incubation time of the MNT for DENV-2 was 10 days. Conclusion: MNT allows the detection of IgG antibodies against DENV-2, provides reliable results and a greater number of samples can be analyzed with material savings.
publishDate 2023
dc.date.none.fl_str_mv 2023-08-02
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2538
10.35663/amp.2023.402.2538
url https://amp.cmp.org.pe/index.php/AMP/article/view/2538
identifier_str_mv 10.35663/amp.2023.402.2538
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2538/1561
dc.rights.none.fl_str_mv Copyright (c) 2023 ACTA MEDICA PERUANA
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 ACTA MEDICA PERUANA
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Colegio Médico del Perú
publisher.none.fl_str_mv Colegio Médico del Perú
dc.source.none.fl_str_mv ACTA MEDICA PERUANA; Vol 40 No 2 (2023): April - June
ACTA MEDICA PERUANA; Vol. 40 Núm. 2 (2023): Abril - Junio
1728-5917
1018-8800
reponame:Acta Médica Peruana
instname:Colegio Médico del Perú
instacron:CMP
instname_str Colegio Médico del Perú
instacron_str CMP
institution CMP
reponame_str Acta Médica Peruana
collection Acta Médica Peruana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1816075112248508416
score 13.95948
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).